文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

346,364+ SCI 论文 与阿拉丁产品引用相关
2,295,288.15 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

热门产品

视图 列表 网格

2 项

设置提升方向
Acaca
LIPIDS · 2020 ·Vol. 55 ·期 3 ·251-260 · IF 1.919

β-Cypermethrin Alleviated the Inhibitory Effect of Medium from RAW 264.7 Cells on 3T3-L1 Cell Maturation into Adipocytes

Bingnan He,Xia Wang,Xini Jin,Zimeng Xue,Yinhua Ni,Jianbo Zhu,Caiyun Wang,Yuanxiang Jin,Zhengwei Fu

Studies have elucidated that pyrethroids induce adipogenesis. It is also known that macrophages can affect the homeostasis of adipose tissue. However, whether and how the β-cypermethrin (β-CYP)-mediated inhibition of the macrophages affects adipogenesis remain unknown. To explore the effects of β-CYP on adipogenesis through modulating the function of macrophages, 3T3-L1 cells, a preadipocyte cell line, were exposed to culture medium from either RAW 264.7 cells, a macrophage cell line (RM), or β-CYP-treated RAW 264.7 cells (CRM). CRM decreased the inhibitory effects of RM treatment on cell proliferation and adipogenesis, as lipid accumulation, the CEBPA content, and Fasn and Acaca expression in 3T3-L1 cells were higher following CRM treatment than following RM treatment through the higher levels of the demethylated CEBPA promoter in 3T3-L1 cells. However, the medium from β-CYP- and N-acetyl-L-cysteine-cotreated RAW 264.7 cells (CNRM) partially restored the inhibitory effects of RAW 264.7 cells on 3T3-L1 cells that had been reduced by CRM, indicating that β-CYP might reduce the cytotoxicity and inhibitory effects of RAW 264.7 cells on the adipogenesis of 3T3-L1 cells through elevating ROS levels in RAW 264.7 cells. Moreover, exposure to β-CYP downregulated the TNF-α secretion in RAW 264.7 cells. In conclusion, these data demonstrated that β-CYP affected the function of RAW 264.7 cells, alleviating their inhibitory effects on adipogenesis and CEBPA demethylation in 3T3-L1 cells. β-CYP might achieve these effects through downregulating the secretion of TNF-α via elevating ROS levels in RAW 264.7 cells. Our experiments provide a new perspective on the obesogenic effect of pyrethroids.

CAS / MDL: 65731-84-2 11061-68-0
研究领域: 毒理学 · 细胞生物学 · 分子生物学
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
PHARMAZIE · 2022 · IF 1.515

Momordica Charantia Alleviates the Lipid Metabolism Disorder of Mice on a High-fat Diet Via Down-regulating ACACA And FASN

Zhou Huiping,Peng Yuxuan,Liu Hongyun,Li Xiaohui,Mei Wenqiu,Li Hao,Xu Kangyan,Hu Meichun,She Tonghui

As a common vegetable, Momordica charantia (M. charantia), also known as bitter melon, has the pharmacological activity of reducing blood sugar and body fat. This experiment explored the effect of M. charantia on the mice liver by adding freeze-dried M. charantia to the feed intake of high-fat diet mice. Among the three groups of normal diet mice (Control), high-fat diet mice fed with lyophilized bitter melon powder (BM) and single high-fat diet mice (HFD), it was seen that the body weight of BM mice did not change apparently (p>0.05), while the body weight of HFD mice increased significantly (p<0.01). Serum triglycerides, total cholesterol, high density lipoprotein cholesterol (HDL-C), Low density lipoprotein cholesterol (LDL-C) of HFD mice was significantly higher than those of Control and BM mice (p<0.01). The results of RT-PCR and Western blot showed that the transcription and protein expression levels of acetyl-CoA carboxylases alpha (ACACA) and fatty acid synthase (FASN) genes in HFD mice were significantly increased (p<0.01), while BM administration could reduce the transcription and expression of these two genes (p<0.01). It is concluded that M. charantia powder alleviates the lipid metabolism disorder of liver in HFD mice via downregulating ACACA and FASN both in the transcription and protein expression levels, and thus exhibits protective effects for the liver.

研究领域: 营养学 · 药理学 · 分子生物学
✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。